20th BioPharma Drug Discovery Nexus Conference

Join Model Medicines in San Diego, California, on May 8-9 for the 20th BioPharma Drug Discovery Nexus Conference. Daniel Haders, the CEO of Model Medicines, will be participating as a panelist, bringing his expertise to the conference. The event covers a wide range of drug discovery topics and offers excellent networking opportunities. Daniel will delve into the theme "Advancing Hit Discovery for Complex and Emerging Targets," aligning seamlessly with Model Medicines' groundbreaking work.

For more information about Model Medicines post-conference, visit www.modelmedicines.com/investors or get in touch with us directly.

Previous
Previous

Dissimilar, Drug-Like, Novel Chemical Entities (DDL-NCEs); Using Multimodal Generative AI

Next
Next

Biochemistry's Hidden Matrix: Atomic Constellations